PTS

Results: 2192



#Item
31SAMPLE BASIC SCREENING SCORE SHEET Listed below are basis scores for screening basic qualifications such as, desired knowledge and various skills and abilities: Education – 70 pts. = Has completed a Ph.D. or related de

SAMPLE BASIC SCREENING SCORE SHEET Listed below are basis scores for screening basic qualifications such as, desired knowledge and various skills and abilities: Education – 70 pts. = Has completed a Ph.D. or related de

Add to Reading List

Source URL: www.lamar.edu

- Date: 2012-01-27 11:48:47
    32Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

    Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

    Add to Reading List

    Source URL: s3.amazonaws.com

    - Date: 2014-09-25 16:16:58
      33Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Wells Messersmith,1

      Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Wells Messersmith,1

      Add to Reading List

      Source URL: publications.oncomed.com

      - Date: 2016-10-08 04:07:44
        34

        PDF Document

        Add to Reading List

        Source URL: www.izumi-pts.co.jp

        - Date: 2016-08-18 19:42:26
          35Final Results of a Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Study E

          Final Results of a Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Study E

          Add to Reading List

          Source URL: s3.amazonaws.com

          - Date: 2015-01-16 14:31:43
            36JanuaryChâteau Péby Faugères 2012 Saint-Emilion Grand Cru Classé  95+ pts by Antonio Galloni

            JanuaryChâteau Péby Faugères 2012 Saint-Emilion Grand Cru Classé 95+ pts by Antonio Galloni

            Add to Reading List

            Source URL: www.chateau-peby-faugeres.com

            - Date: 2016-01-21 06:22:11
              37Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in patients (pts) with recurrent platinum-sensitive ovarian cancer (OC) Roisin O’Cearbhaill1, Scott McM

              Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in patients (pts) with recurrent platinum-sensitive ovarian cancer (OC) Roisin O’Cearbhaill1, Scott McM

              Add to Reading List

              Source URL: s3.amazonaws.com

              - Date: 2016-06-05 05:57:06
                38G£ÓWNY URZ¥D STATYSTYCZNY POLSKIE TOWARZYSTWO STATYSTYCZNE STATYSTYCY POLSCY

                G£ÓWNY URZ¥D STATYSTYCZNY POLSKIE TOWARZYSTWO STATYSTYCZNE STATYSTYCY POLSCY

                Add to Reading List

                Source URL: pts.stat.gov.pl

                  39

                  Załącznik 1. DEKLARACJA CZŁONKA SEKCJI STATYSTYKI MATEMATYCZNEJ POLSKIEGO TOWARZYSTWA STATYSTYCZNEGO

                  Add to Reading List

                  Source URL: pts.stat.gov.pl

                  - Date: 2013-10-15 21:23:00
                    40

                    16 POLSKIE TOWARZYSTWO STATYSTYCZNE

                    Add to Reading List

                    Source URL: pts.stat.gov.pl

                    - Date: 2013-10-15 21:18:00